GNC, USPlabs Settle Class Action Over Recalled Supplements
Law360, Miami (September 23, 2014, 6:05 PM EDT) -- GNC Holdings Inc. and manufacturer USPlabs LLC agreed Monday to pay $2 million to settle a class suit in Florida over the sale of since-recalled diet supplements that have been linked to liver damage.
In a motion filed in the Northern District of Florida, the plaintiffs asked the court to sign off on the deal, which will provide reimbursements for consumers who bought USPlabs' OxyElite Pro and Jack3d lines of products.
The lawsuit claims that GNC sold the supplements, which contain dimethylamylamine, better known as DMAA, and aegeline, despite widespread reports that the products cause severe liver damage.
“Plaintiffs' counsel has...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!